- Home
- PULM vs DLPN Comparison
PULM vs DLPN Comparison
Compare PULM & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- DLPN
- Stock Information
- Founded
- PULM 2003
- DLPN 1996
- Country
- PULM United States
- DLPN United States
- Employees
- PULM N/A
- DLPN N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- DLPN Other Consumer Services
- Sector
- PULM Health Care
- DLPN Consumer Discretionary
- Exchange
- PULM Nasdaq
- DLPN Nasdaq
- Market Cap
- PULM 18.3M
- DLPN 16.9M
- IPO Year
- PULM N/A
- DLPN N/A
- Fundamental
- Price
- PULM $4.87
- DLPN $1.78
- Analyst Decision
- PULM
- DLPN Strong Buy
- Analyst Count
- PULM 0
- DLPN 1
- Target Price
- PULM N/A
- DLPN $5.00
- AVG Volume (30 Days)
- PULM 17.6K
- DLPN 78.8K
- Earning Date
- PULM 10-16-2025
- DLPN 11-13-2025
- Dividend Yield
- PULM N/A
- DLPN N/A
- EPS Growth
- PULM N/A
- DLPN N/A
- EPS
- PULM N/A
- DLPN N/A
- Revenue
- PULM $3,000.00
- DLPN $51,257,243.00
- Revenue This Year
- PULM N/A
- DLPN $9.05
- Revenue Next Year
- PULM $134.88
- DLPN $15.42
- P/E Ratio
- PULM N/A
- DLPN N/A
- Revenue Growth
- PULM N/A
- DLPN 4.84
- 52 Week Low
- PULM $2.00
- DLPN $0.75
- 52 Week High
- PULM $10.40
- DLPN $1.88
- Technical
- Relative Strength Index (RSI)
- PULM 50.82
- DLPN 66.90
- Support Level
- PULM $4.55
- DLPN $1.56
- Resistance Level
- PULM $4.95
- DLPN $1.88
- Average True Range (ATR)
- PULM 0.21
- DLPN 0.15
- MACD
- PULM 0.02
- DLPN 0.03
- Stochastic Oscillator
- PULM 46.72
- DLPN 81.50
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.